Heung‐Woo Park
Papers
1
Total Citations
2
H-Index
1
About
Dr. Heung-Woo Park is a clinician-researcher whose work lies at the intersection of urologic oncology and sarcopenia research, with a particular focus on prostate cancer outcomes. His major contribution involves investigating how preoperative muscle mass—specifically the internal obturator muscle mass index measured via MRI—can serve as a predictive biomarker for biochemical recurrence following radical prostatectomy. In his most cited multi-center study (2021), Dr. Park demonstrated that lower muscle mass, a hallmark of sarcopenia, significantly correlates with poorer oncologic outcomes, offering a novel, non-invasive prognostic tool for risk stratification. This work bridges the gap between cancer survivorship and body composition analysis, highlighting the clinical relevance of muscle health in treatment planning. While his citation count is currently modest, his research addresses a critical, underexplored area in prostate cancer management, with potential to influence preoperative counseling and postoperative surveillance strategies. Dr. Park’s findings contribute to the growing field of cancer cachexia and sarcopenia, positioning him as an emerging voice in personalized, integrative urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1